Safety and efficacy of mitoxantrone in pediatric patients with aggressive MS
Abstract
OBJECTIVE: The purpose of this study was to assess the safety and efficacy of mitoxantrone (MX) in pediatric patients with aggressive multiple sclerosis (MS).
METHODS: A retrospective analysis on pediatric MS patients treated with MX was performed with regards to demographic/clinical parameters and magnetic resonance imaging (MRI) findings..... Read More - http://www.ms-uk.org/paediatric
Safety & efficacy of mitoxantrone in pediatric MS patients
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 217 Views
-
Last post by Petr75
Sat Jan 05, 2019 3:10 am
-
-
IgM+ patients should not be treated with interferon
by frodo » Thu Jul 26, 2018 11:14 pm » in MS Etiology and Pathogenesis - 0 Replies
- 644 Views
-
Last post by frodo
Thu Jul 26, 2018 11:14 pm
-
-
-
Sera from MS patients disrupt the BBB
by frodo » Thu May 17, 2018 9:46 pm » in MS Etiology and Pathogenesis - 0 Replies
- 630 Views
-
Last post by frodo
Thu May 17, 2018 9:46 pm
-
-
-
Opinion: IgM+ patients should not be treated with interferon
by frodo » Thu Jul 26, 2018 11:25 pm » in General Discussion - 0 Replies
- 520 Views
-
Last post by frodo
Thu Jul 26, 2018 11:25 pm
-
-
-
CCSVI: Angioplasty could work in a subgroup of patients
by frodo » Wed Apr 11, 2018 6:45 am » in MS Etiology and Pathogenesis - 0 Replies
- 682 Views
-
Last post by frodo
Wed Apr 11, 2018 6:45 am
-
